on February 10, 2026
Publication: Nature Scientific Reports (peer-reviewed, open source)
This peer-reviewed study, published in Nature Scientific Reports, examines the relationship between meibographic findings and the effectiveness of intense pulsed light (IPL) therapy for meibomian gland dysfunction. The results demonstrate that meibographic imaging is critical for evaluating IPL treatment prognosis.
A key finding is that sequential extreme thinning of the meibomian glands proved to be a more significant prognostic indicator than severe shortening — a distinction that can only be identified through detailed imaging. More importantly, the study found that significant changes observed in the upper eyelid glands may indicate a poor IPL prognosis, highlighting the value of upper lid imaging in guiding treatment decisions.
As IPL therapy becomes increasingly adopted for MGD management, this research underscores the need for comprehensive pre-treatment imaging that includes the upper eyelids. Without it, clinicians may lack the prognostic data needed to set appropriate treatment expectations and tailor their approach.
